Wosulin-30/70

Wockhardt Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Id: f2860882002e6285
Drug Approval Philippines Name: Wosulin-30/70
Product Name: Wosulin-30/70
Registration Number: BRP-054
Brand Name: Wosulin-30/70
Generic Name: Biphasic Isophane Insulin Human (Recombinant DNA Origin)
Dosage Form: Suspension for Injection (SC) (30% Regular Insulin Human/70% Isophane Insulin Human)
Dosage Strength: 100IU/mL
Manufacturer: Wockhardt Ltd.
Importer: Ambica International Corp.
Distributor: GX Laboratories, Inc.
Issuance Date: 28 January 2019
Expiry Date: 10 February 2029
Pharmacologic Category: Intermediate-acting Insulin
Classification: Prescription Drug (RX)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

f2860882002e6285

Type

Standard